Report Detail
Global Cancer Pain Therapeutics Market Insights, Forecast to 2025
- RnM3536266 |
- 17 June, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.
Factors such as the unmet medical needs of patients drive the market growth during the forecast period. Currently, the drugs that are available for reducing pains associated with cancer have a prolonged duration of action and are characterized by undesirable effects like sedation and respiratory depression. Consequently, this presents an opportunity for the vendors to bring in therapies with fewer side effects and a better efficacy parameter.
The global Cancer Pain Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cancer Pain Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Cancer Pain Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Pain Therapeutics in these regions.
This research report categorizes the global Cancer Pain Therapeutics market by top players/brands, region, type and end user. This report also studies the global Cancer Pain Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson＆Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
Market size by Product
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Market size by End User
Paracetamol Treatment-Related Immunotherapy
Radiotherapy
Chemotherapy
Hormone Therapy
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cancer Pain Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cancer Pain Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cancer Pain Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cancer Pain Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cancer Pain Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Pain Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Cancer Pain Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Cancer Pain Therapeutics Market Size Growth Rate by Product
- 1.4.2 Opioids
- 1.4.3 Non-Steroidal Anti-Inflammatory Drugs
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Cancer Pain Therapeutics Market Size Growth Rate by End User
- 1.5.2 Paracetamol Treatment-Related Immunotherapy
- 1.5.3 Radiotherapy
- 1.5.4 Chemotherapy
- 1.5.5 Hormone Therapy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cancer Pain Therapeutics Market Size
- 2.1.1 Global Cancer Pain Therapeutics Revenue 2014-2025
- 2.1.2 Global Cancer Pain Therapeutics Sales 2014-2025
- 2.2 Cancer Pain Therapeutics Growth Rate by Regions
- 2.2.1 Global Cancer Pain Therapeutics Sales by Regions
- 2.2.2 Global Cancer Pain Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Cancer Pain Therapeutics Sales by Manufacturers
- 3.1.1 Cancer Pain Therapeutics Sales by Manufacturers
- 3.1.2 Cancer Pain Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Cancer Pain Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Cancer Pain Therapeutics Revenue by Manufacturers
- 3.2.1 Cancer Pain Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Cancer Pain Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Cancer Pain Therapeutics Price by Manufacturers
- 3.4 Cancer Pain Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Cancer Pain Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cancer Pain Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Cancer Pain Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Cancer Pain Therapeutics Sales by Product
- 4.2 Global Cancer Pain Therapeutics Revenue by Product
- 4.3 Cancer Pain Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Cancer Pain Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Cancer Pain Therapeutics by Countries
- 6.1.1 North America Cancer Pain Therapeutics Sales by Countries
- 6.1.2 North America Cancer Pain Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Cancer Pain Therapeutics by Product
- 6.3 North America Cancer Pain Therapeutics by End User
7 Europe
- 7.1 Europe Cancer Pain Therapeutics by Countries
- 7.1.1 Europe Cancer Pain Therapeutics Sales by Countries
- 7.1.2 Europe Cancer Pain Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cancer Pain Therapeutics by Product
- 7.3 Europe Cancer Pain Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Cancer Pain Therapeutics by Countries
- 8.1.1 Asia Pacific Cancer Pain Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Cancer Pain Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Cancer Pain Therapeutics by Product
- 8.3 Asia Pacific Cancer Pain Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Cancer Pain Therapeutics by Countries
- 9.1.1 Central & South America Cancer Pain Therapeutics Sales by Countries
- 9.1.2 Central & South America Cancer Pain Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Cancer Pain Therapeutics by Product
- 9.3 Central & South America Cancer Pain Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Cancer Pain Therapeutics by Countries
- 10.1.1 Middle East and Africa Cancer Pain Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Cancer Pain Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Cancer Pain Therapeutics by Product
- 10.3 Middle East and Africa Cancer Pain Therapeutics by End User
11 Company Profiles
- 11.1 BioDelivery Science
- 11.1.1 BioDelivery Science Company Details
- 11.1.2 Company Business Overview
- 11.1.3 BioDelivery Science Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 BioDelivery Science Cancer Pain Therapeutics Products Offered
- 11.1.5 BioDelivery Science Recent Development
- 11.2 ProStrakan Group
- 11.2.1 ProStrakan Group Company Details
- 11.2.2 Company Business Overview
- 11.2.3 ProStrakan Group Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 ProStrakan Group Cancer Pain Therapeutics Products Offered
- 11.2.5 ProStrakan Group Recent Development
- 11.3 Teva pharmaceuticals
- 11.3.1 Teva pharmaceuticals Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Teva pharmaceuticals Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Teva pharmaceuticals Cancer Pain Therapeutics Products Offered
- 11.3.5 Teva pharmaceuticals Recent Development
- 11.4 Eli-Lilly
- 11.4.1 Eli-Lilly Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Eli-Lilly Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Eli-Lilly Cancer Pain Therapeutics Products Offered
- 11.4.5 Eli-Lilly Recent Development
- 11.5 Grunenthal Group
- 11.5.1 Grunenthal Group Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Grunenthal Group Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Grunenthal Group Cancer Pain Therapeutics Products Offered
- 11.5.5 Grunenthal Group Recent Development
- 11.6 GW Pharmaceuticals
- 11.6.1 GW Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 GW Pharmaceuticals Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 GW Pharmaceuticals Cancer Pain Therapeutics Products Offered
- 11.6.5 GW Pharmaceuticals Recent Development
- 11.7 Johnson＆Johnson
- 11.7.1 Johnson＆Johnson Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Johnson＆Johnson Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Johnson＆Johnson Cancer Pain Therapeutics Products Offered
- 11.7.5 Johnson＆Johnson Recent Development
- 11.8 Meda Pharmaceuticals
- 11.8.1 Meda Pharmaceuticals Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Meda Pharmaceuticals Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Meda Pharmaceuticals Cancer Pain Therapeutics Products Offered
- 11.8.5 Meda Pharmaceuticals Recent Development
- 11.9 Orexo
- 11.9.1 Orexo Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Orexo Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Orexo Cancer Pain Therapeutics Products Offered
- 11.9.5 Orexo Recent Development
- 11.10 Sanofi
- 11.10.1 Sanofi Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Sanofi Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Sanofi Cancer Pain Therapeutics Products Offered
- 11.10.5 Sanofi Recent Development
- 11.11 WEX Pharmaceuticals
12 Future Forecast
- 12.1 Cancer Pain Therapeutics Market Forecast by Regions
- 12.1.1 Global Cancer Pain Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Cancer Pain Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Cancer Pain Therapeutics Market Forecast by Product
- 12.2.1 Global Cancer Pain Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Cancer Pain Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Cancer Pain Therapeutics Market Forecast by End User
- 12.4 North America Cancer Pain Therapeutics Forecast
- 12.5 Europe Cancer Pain Therapeutics Forecast
- 12.6 Asia Pacific Cancer Pain Therapeutics Forecast
- 12.7 Central & South America Cancer Pain Therapeutics Forecast
- 12.8 Middle East and Africa Cancer Pain Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cancer Pain Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cancer Pain Therapeutics . Industry analysis & Market Report on Cancer Pain Therapeutics is a syndicated market report, published as Global Cancer Pain Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cancer Pain Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
